Acquired xanthinuria

MONDO:0021180

Acquired xanthinuria is generally iatrogenic. Allopurinol treatment, administered to block XOR and prevent uric acid overproduction, leads to the accumulation of xanthine. Rarely, in the setting of aggressive chemotherapy with rapid tumor lysis or in patients with HPRT deficiency on allopurinol therapy, complications of renal failure can develop from xanthine crystal nephropathy.

Also known as: acquired xanthinuria

10 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Sort by